Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This study is to compare the rate and extent of absorption of a single dose of nemolizumab administered with auto-injectors \[AI\] (test) versus dual-chamber syringes \[DCS\] (reference) under controlled conditions in healthy adult subjects.
Epistemonikos ID: 8874d3cfbd470fd6aefa14cbc4375f56d3f03e04
First added on: Oct 02, 2023